GemVax’s highly promising Phase II Alzheimer’s disease clinical trial results targeting telomerase …,

The phase II clinical trial was conducted at twelve domestic institutions to evaluate the safety and efficacy of GV1001, and confirmed statistically …, The phase II clinical trial was conducted at twelve domestic institutions to evaluate the safety and efficacy of GV1001, and confirmed statistically …, Read More

Scroll to Top